Dr. Daniela Brünnert is a senior scientist at the Universitätsklinikum Würzburg. She received the PhD from Heinrich Heine Universität Düsseldorf Mathematisch-Naturwissenschaftliche Fakultät in 2010. Her current research is related to autoimmune diseases, where she develops, expresses, and characterizes specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, she is interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.